Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06074120Not ApplicableCompleted

Low-level Laser Therapy in Genitourinary Symptoms of Menopause

Role: collaborator

NCT06968871Not ApplicableRecruiting

Ameliorated Pap Tests and Cervical Cancer Screening Participation

Role: collaborator

NCT07034859Phase 4Enrolling By Invitation

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

Role: collaborator

NCT06381310Not ApplicableRecruiting

Ultrasound-guided Cannulation of Difficult Hemodialysis Arteriovenous Access

Role: collaborator

All 4 trials loaded